| April 21, 2017 |
SPM-011 has been approved for prioritized review under the SAKIGAKE Designation System.
|
| February 28, 2017 |
A leading-edge project we are collaboratively developing with Sumitomo Heavy Industries,
the “Boron Neutron Capture Therapy (BNCT) System” has been approved for prioritized review under the SAKIGAKE Designation System.
|
| July 14, 2016 |
“Notification of Commencement of Phase II Clinical Trials for Head and Neck Cancer Using
Accelerator BNCT” issued.
|
| March 24, 2016 |
“Concerning Third-Party Share Issuance” publicly released. |
| March 07, 2016 |
“Notification of Commencement of Phase II Clinical Trials Using Accelerator BNCT” issued. |
| September 06, 2012 |
“Notification of Commencement of World’s First Trial Using Accelerator BNCT” issued. |
| April 27, 2012 |
“The Boron Compound Demonstration and Evaluation Innovation Center—toward Cancer Boron Neutron
Capturing Treatment,” a joint project of Osaka Prefecture University and Stella Pharma selected
for the “Innovation Center Furtherance Project (Subsidies for Infrastructure to Demonstrate and
Evaluate Leading-Edge Technology Demonstration),” a project of the Ministry of Economy, Trade
and Industry.
|
Japanese
JP